Esperante Ventures is a corporate venture capital company as an affiliate of a privately-owned global life science group, led by a team experienced in the development, manufacturing and marketing of prescription pharmaceuticals on a worldwide basis. Esperante Ventures has made 28 investments to date in North America, Europe and Israel. Portfolio companies are primarily pharmaceutical therapeutics in Phase 2 or 3 clinical development. Investments are made in syndication with other investors with the aim to generate returns through sale or other liquidity outcomes within a period of 3 years.

Esperante Ventures

Org chart

Teams

Offices